Lopinavir/ritonavir superior choice for ART-experienced patients

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.514, 2006-01, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Darunavir + ritonavir superior to lopinavir/ritonavir for HIV infection

By  

Inpharma, Vol. 1, Iss. 1596, 2007-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Lopinavir/Ritonavir Tablets Compared with Atazanavir plus Ritonavir in Antiretroviral-Experienced Patients in the UK, France, Italy and Spain

By Simpson Kit N.  

Clinical Drug Investigation, Vol. 27, Iss. 12, 2007-01 ,pp. : 807-817

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Lopinavir/Ritonavir Compared with Atazanavir plus Ritonavir in Antiretroviral-Experienced Patients in the US

By Simpson Kit N.  

Clinical Drug Investigation, Vol. 27, Iss. 7, 2007-01 ,pp. : 443-452

Adis International

Access to resources Recommend Favorite

Lopinavir/ritonavir long-term therapy good value for treatment-naive patients

By  

Inpharma, Vol. 1, Iss. 1367, 2002-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Lopinavir/ritonavir long-term therapy good value for treatment-naive patients

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 392, 2002-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite